Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Preliminary Safety and Biomarker Results of the NLRP3 Inflammasome Inhibitor DFV890 in Adult Patients with Myeloid Diseases: A Phase 1b Study
Preliminary Safety and Biomarker Results of the NLRP3 Inflammasome Inhibitor DFV890 in Adult Patients with Myeloid Diseases: A Phase 1b Study Garcia-Manero, G., Abaza, Y., Greenberg, P. L., Haque, T., Kennedy, K., Della Porta, M., Ooi, M. G., Stahl, M., Xie, Z., Mangaonkar, A. A., Desai, P., Dezern, A. E., Garnier, A., Meunier, M., Pelizzari, A., Platzbecker, U., Sockel, K., Kishtagari, A., Lu, H., Manganelli, L., Ji, L., Yan, Z., Li, Y., Roy, M., Gatlik, E., Singh, A., Beaulieu, V., Pelletier, M., Rauch, P., Gill, H. ELSEVIER. 2024: 354-355View details for DOI 10.1182/blood-2024-198326
View details for Web of Science ID 001412359600003